Skip to main content
. 2014 Oct 23;10(5):920–932. doi: 10.5114/aoms.2014.46212

Figure 7.

Figure 7

Proportion of patients with chronic HF receiving ACE inhibitor/ARB and/or spironolactone according to the estimated glomerular filtration rate (eGRF)